345 results on '"McLeod, D G"'
Search Results
2. Elevated osteonectin/SPARC expression in primary prostate cancer predicts metastatic progression
3. Overexpression of C-MYC oncogene in prostate cancer predicts biochemical recurrence
4. Quantitative expression of TMPRSS2 transcript in prostate tumor cells reflects TMPRSS2–ERG fusion status
5. TMPRSS2-ERG fusion, a common genomic alteration in prostate cancer activates C-MYC and abrogates prostate epithelial differentiation
6. Transcriptome analyses of benign and malignant prostate epithelial cells in formalin-fixed paraffin-embedded whole-mounted radical prostatectomy specimens
7. Androgen receptor mutation (T877A) promotes prostate cancer cell growth and cell survival
8. Quantitative expression profile of PSGR in prostate cancer
9. External beam radiation therapy after radical prostatectomy: efficacy and impact on urinary continence
10. p53 Immunostaining guided laser capture microdissection (p53-LCM) defines the presence of p53 gene mutations in focal regions of primary prostate cancer positive for p53 protein
11. Pentosan polysulfate decreases prostate smooth muscle proliferation and extracellular matrix turnover
12. Androgen deprivation in men with prostate cancer is associated with an increased rate of bone loss
13. Primary hormonal therapy for prostate cancer: experience with 135 consecutive PSA-ERA patients from a tertiary care military medical center
14. PHOTOPERIODIC TERMINATION OF DIAPAUSE IN AN INSECT
15. ERG oncoprotein expression in prostate cancer: clonal progression of ERG-positive tumor cells and potential for ERG-based stratification
16. Do patients with low volume prostate cancer have prostate specific antigen recurrence following radical prostatectomy?
17. Dispersal ofAleochara bilineata [Col.: Staphylinidae] following inundative releases in urban gardens
18. Evaluation of whole-mount prostate derived tissue arrays by immunostaining of p53 and bcl-2 proteins to predict prostate cancer recurrence
19. Her2/neu expression in patients at high risk for progression following radical prosatectomy
20. Primary malignant melanoma of the scrotum
21. Erratum: Elevated osteonectin/SPARC expression in primary prostate cancer predicts metastatic progression
22. Realization via Dynamic Testing with Glass-Fibre Reinforced Plastics - Interpretations for Bumper Systems
23. An Anatomical Skull for Impact Testing
24. A Basis for Crash Dummy Skull and Head Geometry
25. Erratum: Frequent overexpression of ETS-related gene-1 (ERG1) in prostate cancer transcriptome
26. Erratum: Elevated osteonectin/SPARC expression in primary prostate cancer predicts metastatic progression
27. Elevated osteonectin/SPARC expression in primary prostate cancer predicts metastatic progression
28. Sipuleucel-T in African Americans: A subgroup analysis of three phase III sipuleucel-T trials in advanced prostate cancer.
29. ERG protein expression in prostate and vascular tumors: A potential for ERG-based stratification.
30. Prostate cancer in men under the age of 50: A comparison of race and outcomes.
31. Quantitative expression of TMPRSS2 transcript in prostate tumor cells reflects TMPRSS2–ERG fusion status
32. Long-term follow-up assessment of a HER-2/neu peptide (E75) vaccine for the prevention of recurrence in high-risk prostate cancer patients
33. Gynecomastia in patients with prostate cancer:a review of treatment options
34. Transcriptome analyses of benign and malignant prostate epithelial cells in formalin-fixed paraffin-embedded whole-mounted radical prostatectomy specimens
35. The influence of nodal status on progression outcomes in patients with prostate cancer: Data from the Early Prostate Cancer program at 7.4 years
36. Prostate-specific antigen velocity and the odds of detecting gleason 8 to 10 prostate cancer at biopsy
37. Cancer-specific survival following radical prostatectomy or radiation therapy and short course hormonal therapy in men with localized, unfavorable-risk prostate cancer
38. Delaying metastatic disease progression in locally advanced disease − Results from the Early Prostate Cancer program at a median follow-up of 7.4 years
39. Effect of bicalutamide 150 mg on PSA progression in M0 prostate cancer: Results from the Early Prostate Cancer program
40. Sarcoidosis of the prostate
41. Quantitative expression profile of PSGR in prostate cancer
42. Cost of crop losses in processing tomato and cabbage in southwestern Ontario due to insects, weeds and/or diseases
43. Polymeric Nanocomposites for Automotive Applications
44. RE: DETECTION OF CIRCULATING PROSTATE SPECIFIC ANTIGEN EXPRESSING PROSTATIC CELLS IN THE BONE MARROW OF RADICAL PROSTATECTOMY PATIENTS BY SENSITIVE REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION
45. RE: DETECTION OF CIRCULATING PROSTATE SPECIFIC ANTIGEN EXPRESSING PROSTATIC CELLS IN THE BONE MARROW OF RADICAL PROSTATECTOMY PATIENTS BY SENSITIVE REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION
46. Bilateral Orchiectomy With or Without Flutamide for Metastatic Prostate Cancer
47. Correlation of Measured and Computed Radiation Intensity Exiting a Packed Bed
48. The use of flutamide in hormone-refractory metastatic prostate cancer
49. Use of Glycosylated Hemoglobin to Identify Diabetics at High Risk for Penile Periprosthetic Infections
50. Phenology and Field Biology of Black Cutworm (Lepidoptera: Noctuidae) in Ontario No-Till Corn.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.